Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 4 | 7 |
| List of Tables | 8 | 1 |
| List of Figures | 9 | 2 |
| Contract Research Outsourcing Introduction | 11 | 1 |
| GBI Research Report Guidance | 11 | 1 |
| Top 20 Contract Research Organizations Overview | 12 | 8 |
| Global Contract Research Outsourcing | 12 | 1 |
| The Clinical Research Process | 13 | 1 |
| Drug Discovery Phase | 13 | 1 |
| Pre-Clinical Phase | 14 | 1 |
| Phase I | 14 | 1 |
| Phase II | 14 | 1 |
| Phase III | 14 | 1 |
| Review and Approval from the Regulatory Agencies | 14 | 1 |
| Post-Marketing Studies | 14 | 1 |
| Outsourcing of Clinical Research and Trial Processes | 15 | 1 |
| Clinical Research Outsourcing Perceived to be a Solution to Problems Such as Rising Costs or Low Productivity | 15 | 1 |
| Strategic Outsourcing Improves Value for Outsourcing Companies | 15 | 1 |
| Key Reasons for Outsourcing to Contract Research Organizations | 16 | 1 |
| Gaining Cost Reductions is a Key Reason for Contract Research Outsourcing | 17 | 1 |
| CROs Engaged in Reducing Time to Market in Order to Achieve a Competitive Edge | 17 | 1 |
| Data Management Allows Biopharmaceutical Companies to Focus on Core Competencies | 18 | 1 |
| Evolving Risk Sharing Agreements Encourage Biopharmaceutical Companies to Increase Contract Research Outsourcing | 18 | 1 |
| CROs Help to Improve Clinical Research Quality | 18 | 1 |
| Small and Medium Biopharmaceutical Companies can Capitalize on the Resources of CROs | 19 | 1 |
| Biopharmaceutical Companies Benefit from New Technologies | 19 | 1 |
| Contract Research Outsourcing Geographical Landscape | 20 | 12 |
| Emerging Regions in the Global Contract Research Outsourcing Market | 21 | 1 |
| Latin America | 21 | 1 |
| Potential Advantages of the Latin American Contract Research Outsourcing Market | 21 | 1 |
| Central and Eastern Europe (CEE) | 21 | 1 |
| Potential Advantages of Central and East European Contract Research Outsourcing Market | 22 | 1 |
| India | 22 | 1 |
| Potential Advantages of the Indian Contract Research Outsourcing Market | 22 | 1 |
| China | 23 | 1 |
| Potential Advantages of the Chinese Contract Research Outsourcing Market | 23 | 1 |
| Why India and China? | 24 | 1 |
| Availability of Skilled Manpower | 24 | 2 |
| Scale of Available Resources for Clinical Development | 26 | 1 |
| Improved IP Protection in India and China | 26 | 1 |
| Government Support for the Drug Discovery Development | 27 | 1 |
| China | 27 | 1 |
| India | 27 | 1 |
| Risk Sharing Agreements: A Step Forward by Indian and Chinese Companies | 28 | 1 |
| Hutchison MediPharma with Merck KGaA and Eli Lilly &Co | 29 | 1 |
| Advinus Therapeutics with Ortho-McNeil-Janssen Pharmaceutical Inc, Genzyme Corporation and Merck &Co | 29 | 1 |
| Ranbaxy with Merck &Co and GlaxoSmithKline | 29 | 1 |
| SWOT Analysis | 29 | 2 |
| Conclusion | 31 | 1 |
| Top 20 Contract Research Organizations Service Models | 32 | 3 |
| Contract Research Outsourcing Service Model | 32 | 1 |
| Fully Integrated Service Model | 32 | 1 |
| Functional Service Model | 33 | 1 |
| Criteria for Selecting a Contract Research Organization | 34 | 1 |
| Top 20 Contract Research Organizations Market Characterization | 35 | 6 |
| The Contract Research Outsourcing Market will be Driven by Demand from Biopharmaceutical Industry | 35 | 1 |
| Key Market Drivers | 36 | 1 |
| Increasing R&D Expenditure and Decreasing Productivity in the Biopharmaceutical Industry | 36 | 1 |
| Stringent Regulations and Complex Clinical Trials | 36 | 1 |
| Restriction on Pricing and Reimbursement of Drugs | 37 | 1 |
| Increasing Number of Clinical Trials | 37 | 1 |
| Key Market Restraints/Challenges | 38 | 1 |
| Quality Concerns | 38 | 1 |
| Economic Recession | 38 | 1 |
| Contract Research Outsourcing Market Trends | 39 | 1 |
| Increase in the Number of Services Focusing on Late Stage Clinical Development | 39 | 1 |
| Globalization of Clinical Research and Trials | 39 | 1 |
| Strategic Partnerships with CROs | 40 | 1 |
| Advanced Technology to Enhance Drug Discovery Process | 40 | 1 |
| Top 20 Contract Research Organizations Competitive Landscape | 41 | 70 |
| Overview | 41 | 1 |
| Market Share Analysis and Competitive Profiling | 42 | 1 |
| Quintiles Transnational Corp. | 43 | 1 |
| Business Description | 43 | 1 |
| Snapshot | 44 | 1 |
| Strategic Consolidations | 45 | 3 |
| Financial Information | 48 | 1 |
| SWOT Analysis | 49 | 1 |
| Covance | 50 | 1 |
| Business Description | 50 | 1 |
| Snapshot | 50 | 1 |
| Strategic Consolidations | 51 | 1 |
| Financial Information | 52 | 1 |
| SWOT Analysis | 53 | 1 |
| Pharmaceutical Product Development | 54 | 1 |
| Business Description | 54 | 1 |
| Snapshot | 54 | 1 |
| Strategic Consolidations | 55 | 4 |
| Financial Information | 59 | 1 |
| SWOT Analysis | 60 | 1 |
| Charles River Laboratories | 61 | 1 |
| Business Description | 61 | 1 |
| Snapshot | 61 | 1 |
| Strategic Consolidations | 62 | 2 |
| Financial Information | 64 | 1 |
| SWOT Analysis | 65 | 1 |
| PAREXEL | 66 | 1 |
| Business Description | 66 | 1 |
| Snapshot | 66 | 1 |
| Strategic Consolidations | 67 | 2 |
| Financial Information | 69 | 1 |
| SWOT Analysis | 70 | 1 |
| ICON | 71 | 1 |
| Business Overview | 71 | 1 |
| Snapshot | 71 | 1 |
| Strategic Consolidations | 72 | 1 |
| Financial Information | 73 | 1 |
| INC Research | 74 | 1 |
| Business Description | 74 | 1 |
| Snapshot | 74 | 1 |
| Strategic Consolidations | 75 | 1 |
| Financial Information | 76 | 1 |
| PharmaNet Development Group Inc. | 77 | 1 |
| Business Description | 77 | 1 |
| Snapshot | 77 | 1 |
| Strategic Consolidations | 78 | 1 |
| Financial Information | 79 | 1 |
| PRA International | 80 | 1 |
| Business Overview | 80 | 1 |
| Snapshot | 80 | 1 |
| Strategic Consolidations | 81 | 1 |
| CMIC | 82 | 1 |
| Business Description | 82 | 1 |
| Snapshot | 82 | 1 |
| Strategic Consolidations | 83 | 1 |
| Financial Information | 84 | 1 |
| WuXi AppTec | 85 | 1 |
| Business Description | 85 | 1 |
| Snapshot | 85 | 1 |
| Strategic Consolidations | 86 | 1 |
| Financial Information | 87 | 1 |
| Galapagos NV | 87 | 1 |
| Business Description | 87 | 1 |
| BioFocus | 88 | 1 |
| Snapshot | 88 | 1 |
| Strategic Consolidations | 89 | 5 |
| Financial Information | 94 | 1 |
| LAB Research Inc | 95 | 1 |
| Business Description | 95 | 1 |
| Snapshot | 95 | 1 |
| Strategic Consolidations | 96 | 1 |
| Financial Information | 96 | 1 |
| ReSearch Pharmaceutical Services | 97 | 1 |
| Business Description | 97 | 1 |
| Snapshot | 97 | 1 |
| Strategic Consolidations | 98 | 1 |
| Financial Information | 99 | 1 |
| Omnicare Clinical Research, Inc | 99 | 1 |
| Business Overview | 99 | 1 |
| Snapshot | 100 | 1 |
| Strategic Consolidations | 100 | 1 |
| SGS | 101 | 1 |
| Business Description | 101 | 1 |
| Snapshot | 101 | 1 |
| United BioSource Corporation | 102 | 1 |
| Business Description | 102 | 1 |
| Snapshot | 102 | 1 |
| Strategic Consolidations | 103 | 1 |
| BioClinica | 104 | 1 |
| Business Description | 104 | 1 |
| Snapshot | 104 | 1 |
| Strategic Consolidations | 104 | 1 |
| Financial Information | 105 | 1 |
| Aptuit | 106 | 1 |
| Business Overview | 106 | 1 |
| Snapshot | 106 | 1 |
| Strategic Consolidations | 107 | 1 |
| Chiltern | 108 | 1 |
| Business Overview | 108 | 1 |
| Snapshot | 108 | 1 |
| Strategic Consolidations | 109 | 1 |
| Financial Information | 110 | 1 |
| Top 20 Contract Research Organizations - Appendix | 111 | 4 |
| Market Definitions | 111 | 1 |
| Abbreviations | 111 | 1 |
| Research Methodology | 112 | 2 |
| Coverage | 112 | 1 |
| Secondary Research | 113 | 1 |
| Primary Research | 113 | 1 |
| Expert Panel Validation | 113 | 1 |
| Contact Us | 114 | 1 |
| Disclaimer | 114 | 1 |
| Sources | 114 | 1 |